Department of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Sci Rep. 2023 Jan 5;13(1):223. doi: 10.1038/s41598-023-27476-9.
This study aimed to develop a predictive system for prognostic evaluation of osteosarcoma patients. We obtained osteosarcoma sample data from 1998 to 2016 using SEER*Stat software version 8.3.8, and established a multivariable Cox regression model using R-4.0.3 software. Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The diagnosis of the model was completed through influential cases, proportionality, and multicollinearity. The predictive ability of the model was tested using area under the curve (AUC), calibration curves, and Brier scores. Finally, the bootstrap method was used to internally verify the model. In total, data from 3566 patients with osteosarcoma were included in this study. The multivariate Cox regression model was used to determine the independent prognostic variables. A nomogram and Kaplan-Meier survival curve were established. The AUC and Brier scores indicated that the model had a good predictive calibration. In addition, we found that the radiotherapy appears to be a risk factor of patients with osteosarcoma and made a discussion. We developed a prognostic evaluation system for patients with osteosarcoma for 1-, 3-, and 5-year overall survival with good predictive ability using sample data extracted from the SEER database. This has important clinical significance for the early identification and treatment of high-risk groups of osteosarcoma patients.
本研究旨在开发一个用于骨肉瘤患者预后评估的预测系统。我们使用 SEER*Stat 软件版本 8.3.8 从 1998 年至 2016 年获得骨肉瘤样本数据,并使用 R-4.0.3 软件建立了多变量 Cox 回归模型。数据从 Surveillance, Epidemiology, and End Results(SEER)数据库中提取。通过影响病例、比例和多重共线性来完成模型的诊断。使用曲线下面积(AUC)、校准曲线和 Brier 评分来测试模型的预测能力。最后,使用 bootstrap 方法对模型进行内部验证。本研究共纳入 3566 例骨肉瘤患者的数据。使用多变量 Cox 回归模型确定独立的预后变量。建立了列线图和 Kaplan-Meier 生存曲线。AUC 和 Brier 评分表明该模型具有良好的预测校准能力。此外,我们发现放疗似乎是骨肉瘤患者的一个危险因素,并进行了讨论。我们使用从 SEER 数据库中提取的样本数据开发了一个用于骨肉瘤患者 1 年、3 年和 5 年总生存率的预后评估系统,具有良好的预测能力。这对于早期识别和治疗骨肉瘤高危患者具有重要的临床意义。